Pipeline

Astex Pharmaceuticals™ has established a strong pipeline of small molecule, molecularly targeted drugs. SGI-110 and AT13387 are prioritized and advancing in multiple, potential indications.

Partnered Products and Programs

Astex’s partners are advancing several Astex compounds in clinical trials. These trials are completely funded and executed by our partners.

Compound Name / Mechanism

Discovery

Preclinical

Phase 1

Phase 2

Partner

Discovery milestones achieved
  • gsk